M. Levacher

782 total citations
25 papers, 655 citations indexed

About

M. Levacher is a scholar working on Immunology, Infectious Diseases and Virology. According to data from OpenAlex, M. Levacher has authored 25 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Infectious Diseases and 6 papers in Virology. Recurrent topics in M. Levacher's work include HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (5 papers) and HIV/AIDS Research and Interventions (4 papers). M. Levacher is often cited by papers focused on HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (5 papers) and HIV/AIDS Research and Interventions (4 papers). M. Levacher collaborates with scholars based in France and United States. M. Levacher's co-authors include J J Pocidalo, Bruce Allen Bach, Frank Hulstaert, B Rouveix, Marie‐Christine Dazza, E Dournon, Sophie Matheron, Christophe Michon, B. Régnier and P. de Truchis and has published in prestigious journals such as The Lancet, Journal of Applied Physiology and Journal of Clinical Microbiology.

In The Last Decade

M. Levacher

23 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Levacher France 12 320 243 212 159 68 25 655
Ronald D’Amico United States 19 364 1.1× 528 2.2× 156 0.7× 238 1.5× 63 0.9× 70 942
Joel Weaver Canada 9 189 0.6× 151 0.6× 109 0.5× 68 0.4× 159 2.3× 11 478
Dean Follman United States 6 192 0.6× 110 0.5× 395 1.9× 123 0.8× 39 0.6× 7 712
Ping Ruan United States 14 121 0.4× 161 0.7× 45 0.2× 177 1.1× 145 2.1× 25 557
Carl Johan Treutiger Sweden 13 130 0.4× 115 0.5× 564 2.7× 285 1.8× 192 2.8× 22 1.2k
Mohammad Khalid Saudi Arabia 12 171 0.5× 109 0.4× 127 0.6× 108 0.7× 125 1.8× 50 539
Gerond Lake‐Bakaar United States 17 57 0.2× 227 0.9× 84 0.4× 454 2.9× 96 1.4× 52 1.1k
Shigeki Nabeshima Japan 17 73 0.2× 130 0.5× 208 1.0× 289 1.8× 86 1.3× 68 713
P A Batman United Kingdom 15 151 0.5× 122 0.5× 42 0.2× 228 1.4× 77 1.1× 21 616

Countries citing papers authored by M. Levacher

Since Specialization
Citations

This map shows the geographic impact of M. Levacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Levacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Levacher more than expected).

Fields of papers citing papers by M. Levacher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Levacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Levacher. The network helps show where M. Levacher may publish in the future.

Co-authorship network of co-authors of M. Levacher

This figure shows the co-authorship network connecting the top 25 collaborators of M. Levacher. A scholar is included among the top collaborators of M. Levacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Levacher. M. Levacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rouveix, B, J. P. Giroud, & M. Levacher. (2001). G-CSF : mécanisme d'action et activité anti-infectieuse. 3(2). 83–89. 1 indexed citations
3.
Allanore, Yannick, Didier Borderie, Pascal Hilliquin, et al.. (2001). Low levels of nitric oxide (NO) in systemic sclerosis: inducible NO synthase production is decreased in cultured peripheral blood monocyte/macrophage cells. Lara D. Veeken. 40(10). 1089–1096. 32 indexed citations
4.
Levacher, M., F. Bouscarat, Roland Landman, et al.. (2000). Frequency of Cytokine-Producing T Cells in HIV-Infected Patients Treated with Stavudine, Didanosine, and Ritonavir. AIDS Research and Human Retroviruses. 16(17). 1869–1875. 6 indexed citations
5.
Bouscarat, F., M. Levacher, Marie‐Christine Dazza, et al.. (1999). Prospective Study of CD8 + Lymphocyte Activation in Relation to Viral Load in HIV-Infected Patients with >=400 CD4 + Lymphocytes per Microliter. AIDS Research and Human Retroviruses. 15(16). 1419–1425. 18 indexed citations
6.
Rouveix, B, et al.. (1999). [Drugs for respiratory tropism and pregnancy].. PubMed. 55(5). 338–43. 3 indexed citations
7.
Bouscarat, F., M. Levacher, Martine Muffat‐Joly, et al.. (1998). Changes in blood CD8+ lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS. 12(11). 1267–1273. 58 indexed citations
8.
Hayem, Gilles, et al.. (1994). Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents. Antimicrobial Agents and Chemotherapy. 38(2). 243–247. 63 indexed citations
9.
Levacher, M., et al.. (1992). The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value. Clinical & Experimental Immunology. 90(3). 376–382. 148 indexed citations
10.
Levacher, M., et al.. (1990). T activation marker evaluation in ARC patients treated with AZT. Comparison with CD4+ lymphocyte count in non-progressors and progressors towards AIDS. Clinical & Experimental Immunology. 81(2). 177–182. 30 indexed citations
11.
Rouveix, B, et al.. (1989). Effect of zinc on the immune status of zinc-depleted AIDS related complex patients. Clinical Nutrition. 8(5). 259–261. 20 indexed citations
12.
Levacher, M., et al.. (1988). Genetic differences in response to pulmonary cytochrome P-450 inducers and oxygen toxicity. Journal of Applied Physiology. 64(4). 1376–1381. 36 indexed citations
13.
Dournon, E, Willy Rozenbaum, Christophe Michon, et al.. (1988). EFFECTS OF ZIDOVUDINE IN 365 CONSECUTIVE PATIENTS WITH AIDS OR AIDS-RELATED COMPLEX. The Lancet. 332(8623). 1297–1302. 153 indexed citations
14.
Rouveix, B, et al.. (1987). Beta-lactam antibiotics and human lymphocyte function: The in vitro effect on blastogenesis, lymphokine production and suppressor cell functions. International Journal of Immunopharmacology. 9(5). 567–575. 6 indexed citations
15.
Levacher, M., et al.. (1986). Diethyldithiocarbamate provides partial protection against pulmonary and lymphoid oxygen toxicity.. Journal of Pharmacology and Experimental Therapeutics. 236(2). 476–480. 20 indexed citations
16.
Rouveix, B, et al.. (1986). Activated human lymphocytes secrete a soluble factor that aggregates leukocytes. Cellular Immunology. 99(2). 385–394. 2 indexed citations
17.
Azoulay-Dupuis, E., M. Levacher, Martine Muffat‐Joly, & J J Pocidalo. (1985). Humoral immunodepression following acute No2exposure in normal and adrenalectomized mice. Journal of Toxicology and Environmental Health. 15(1). 149–162. 7 indexed citations
18.
Rouveix, B, Francis Derouin, & M. Levacher. (1985). Evaluation of cellular immune response during chronic schistosomiasis in humans by the leukocyte aggregation test and the leukocyte migration inhibition test. Journal of Clinical Microbiology. 21(4). 649–651. 1 indexed citations
19.
Levacher, M., B Rouveix, & P. Badenoch‐Jones. (1983). Diagnosis of penicillin allergy. Clinical & Experimental Allergy. 13(1). 21–29. 7 indexed citations
20.
Rouveix, B, et al.. (1982). Lymphoid tissu depression induced by normobaric oxygen. Its prevention by endotoxin in rat. International Journal of Immunopharmacology. 4(4). 363–363. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026